These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1486 related items for PubMed ID: 1639948
21. Sperm motion parameters after suppression of spermatogenesis with a gonadotropin-releasing hormone antagonist plus testosterone supplementation. Bastias MC, Kamijo H, Pavlou SN. Fertil Steril; 1993 Jun; 59(6):1261-5. PubMed ID: 8495775 [Abstract] [Full Text] [Related]
22. The potential for an androgen male contraceptive. Cunningham GR, Silverman VE, Thornby J, Kohler PO. J Clin Endocrinol Metab; 1979 Oct; 49(4):520-6. PubMed ID: 479345 [Abstract] [Full Text] [Related]
31. A combined regimen of cyproterone acetate and testosterone enanthate as a potentially highly effective male contraceptive. Meriggiola MC, Bremner WJ, Paulsen CA, Valdiserri A, Incorvaia L, Motta R, Pavani A, Capelli M, Flamigni C. J Clin Endocrinol Metab; 1996 Aug; 81(8):3018-23. PubMed ID: 8768868 [Abstract] [Full Text] [Related]
32. Hormonal effects of GnRH agonist in the human male: an approach to male contraception using combined androgen and GnRH agonist treatment. Swerdloff RS, Handelsman DJ, Bhasin S. J Steroid Biochem; 1985 Nov; 23(5B):855-61. PubMed ID: 2934582 [Abstract] [Full Text] [Related]
33. Influence of simultaneous gonadotropin-releasing hormone agonist and testosterone treatment on spermatogenesis and potential fertilizing capacity in male monkeys. Mann DR, Gould KG, Smith MM, Duffey T, Collins DC. J Clin Endocrinol Metab; 1987 Dec; 65(6):1215-24. PubMed ID: 3316265 [Abstract] [Full Text] [Related]
34. Novel male hormonal contraceptive combinations: the hormonal and spermatogenic effects of testosterone and levonorgestrel combined with a 5alpha-reductase inhibitor or gonadotropin-releasing hormone antagonist. Matthiesson KL, Amory JK, Berger R, Ugoni A, McLachlan RI, Bremner WJ. J Clin Endocrinol Metab; 2005 Jan; 90(1):91-7. PubMed ID: 15509637 [Abstract] [Full Text] [Related]
35. Hormonal responses to a potent gonadotropin hormone-releasing hormone antagonist in normal elderly men. Tenover JS, Dahl KD, Vale WW, Rivier JE, Bremner WJ. J Clin Endocrinol Metab; 1990 Oct; 71(4):881-8. PubMed ID: 2205625 [Abstract] [Full Text] [Related]
36. Suppression of spermatogenesis to azoospermia by combined administration of GnRH antagonist and 19-nortestosterone cannot be maintained by this non-aromatizable androgen alone. Behre HM, Kliesch S, Lemcke B, von Eckardstein S, Nieschlag E. Hum Reprod; 2001 Dec; 16(12):2570-7. PubMed ID: 11726576 [Abstract] [Full Text] [Related]
37. Inhibition of spermatogenesis in men using various combinations of oral progestagens and percutaneous or oral androgens. Guerin JF, Rollet J. Int J Androl; 1988 Jun; 11(3):187-99. PubMed ID: 2970439 [Abstract] [Full Text] [Related]
38. Intermittent long-term administration of a potent gonadotropin-releasing hormone agonist in normal men. Doelle G, Linde R, Alexander N, Kirchner F, Vale W, Rivier J, Rabin D. Int J Fertil; 1982 Jun; 27(4):234-7. PubMed ID: 6131043 [Abstract] [Full Text] [Related]
39. Heterogeneity of sperm density profiles following 16-week therapy with continuous infusion of high-dose LHRH analog plus testosterone. Pavlou SN, Interlandi JW, Wakefield G, Rivier J, Vale W, Rabin D. J Androl; 1986 Jun; 7(4):228-33. PubMed ID: 3528106 [Abstract] [Full Text] [Related]
40. Testosterone prevents complete suppression of spermatogenesis in the gonadotropin-releasing hormone antagonist-treated nonhuman primate (Macaca fascicularis). Weinbauer GF, Göckeler E, Nieschlag E. J Clin Endocrinol Metab; 1988 Aug; 67(2):284-90. PubMed ID: 3292557 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]